The Early Drug Development Center (EDDC) treatment team is comprised of a multidisciplinary group of medical oncologists, cardiologists, nephrologists, nursing staff and researchers who specialize in designing, conducting and analyzing clinical trials of experimental medicines to ensure that your treatment is closely monitored and safe. In addition, the EDDC targets disease-specific malignancies by collaborating with Dana-Farber clinicians across all treatment centers who are dedicated to improving your care with their expertise.
Early Drug Development Center Clinicians
Geoffrey Shapiro, MD, PhD, Disease Center Leader
Khanh Do, MD, Clinical Director
Aparna Mani, MD, PhD
Andrew Wolanski, NP
Disease Center Collaborators
Elizabeth Buchbinder, MD, Melanoma Cancer Treatment Center
Nicole Chau, MD, Head and Neck Cancer Treatment Center
Atish Choudhury, MD, PhD, Genitourinary Treatment Center
James Cleary, MD, PhD, Gastrointestinal Cancer Treatment Center
Sara Tolaney, MD, Breast Cancer Treatment Center
Program Nurse
Brian Beardslee, RN
Research Nurses
Amy Carrier, RN, BSN
Faith Hassinger, RN, BSN
Julia Hewes, RN
Elizabeth McCarthy, RN, BSN
Rachel Patchel, RN, BSN
Clinical Research Manager
Ketki Bhushan, MPH
Regulatory Coordinators
Elizabeth Downey
Marissa Marzano
Solida Pruitt-Thompson
Senior Clinical Research Coordinators
Dongpo Cai
Illy Dixon
Matt Milstein
Clinical Research Coordinators
Sarah Desmarais
Courtney Gannon
Liz O'Brien
Amber Scotton